Ayuda
Ir al contenido

Dialnet


Resumen de Criteria and indicators to evaluate quality of care in genitourinary tumour boards

Javier Puente Vázquez, Daniel Castellano-Gauna, Ignacio Durán, Paula Gratal, María Teresa Pardo, Vicente Guillem Porta, F. Algaba, Óscar Buisán Rueda, Juan José Fernández Ávila, A. Gómez-Iturriaga, Mariano José Parada Blázquez, Daniel Adolfo Pérez Fentes, Gemma Sancho, Juan Antonio Vallejo Casas

  • Purpose Genitourinary (GU) multidisciplinary tumour boards (GUMTBs) are key components of patient care, as they might lead to changes in treatment plan, improved survival, and increased adherence to guidelines. However, there are no guidelines on how GUMTBs should operate or how to assess their quality of performance.

    Methods A systematic literature review was conducted to identify criteria and indicators to evaluate quality in GUMTBs. A scientifc committee—comprising 12 GU cancer specialists from seven disciplines—proposed a list of criteria and developed indicators, evaluated in two rounds of Delphi method. Appropriateness and utility of indicators were scored using a 9-point Likert scale. Consensus was defned as at least two-thirds of Delphi respondents selecting a score sub-category that encompassed the median score of the group.

    Results Forty-fve criteria were selected to evaluate the quality of GUMTBs covering fve dimensions: organisation, personnel, protocol and documentation, resources, and interaction with patients. Then, 33 indicators were developed and evaluated in the frst round of Delphi, leading to a selection of 26 indicators in two dimensions: function, governance and resources, and GUMTB sessions. In the second round, consensus was reached on the appropriateness of all 26 indicators and on the utility of 24 of them. Index cards for criteria and indicators were developed to be used in clinical practice.

    Conclusions Criteria and indicators were developed to evaluate the quality of GUMTBs, aiming to serve as a guide to improve quality of care and health outcomes in patients with GU cancer.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus